Whereas previous studies had shown that myc plus over-expression of Bcl-2 synergized to accelerate lymphomagenesis in the Eu-myc model [40], the genetic ablation of Bcl-2 had no impact on the cancer phenotype. The gene discussed is MYC; the disease is cancer.